Cyclodextrin                                                               Product, Process, Material Safety Data Sheet, Patent, Consultants, Application  
Primary Information Services 
              
Home. Ordering Information. Contact                

     Information  @ a Glance 

General
  • Lamivudine  is a potent nucleoside analog reverse transcriptase inhibitor.
  • Lamivudine is administered orally, and it is rapidly absorbed with a bio-availability of over 80%. Some research suggests that lamivudine can cross the blood-brain barrier.

Process

  • Lamivudine is an analogue of cytidine.
  • It can inhibit both types of HIV reverse transcriptase and also the reverse transcriptase of hepatitis B.
  • It needs to be phosphorylated to its triphosphate form before it is active.
  • 3TC-triphosphate also inhibits cellular DNA polymerase.

Report

  • Lamivudine is a nucleoside analogue, which was originally licensed for the treatment of HIV.
  • It is now additionally licensed for the treatment of chronic hepatitis B with evidence of viral replication.
  • It is marketed by GlaxoSmithKline with the brand names Zeffix, Heptovir, Epivir, and Epivir-HBV.

Application

  • Lamivudine has been used for treatment of chronic hepatitis B at a lower dose than for treatment of HIV.
  • It improves the sero conversion of e-antigen positive hepatitis B and also improves histology staging of the liver.

        Entrepreneur who want the information on Product, Process, Market, Msds, Patent, Consultants, Application Can email us to informer@eth.net , primaryinfo@gmail.com

Primary Information Services
 21 Murugappan St, SwamyNagar Ext2, 
Ullagaram, Chennai - 600091, India.
 Phone: 91 44 22421080  Email :
informer@eth.net , primaryinfo@gmail.com
Mobile number: 9940043898, 9444008898  Fax : 91 44 22423753